CNBC’s Jim Cramer on Friday pointed out the number of biopharma mergers and acquisitions that have closed or been announced over the last few months. He...
If you don’t know a soul that is bullish — and I mean flat-out positive — you may need some new friends. We will soon see...
It’s certainly been a volatile time for markets. A rough August ended with a bounce on Wall Street last week, although stocks finished Tuesday in the...
The Amgen logo is displayed outside Amgen headquarters on May 17, 2023 in Thousand Oaks, California. Mario Tama | Getty Images The Federal Trade Commission on...
Robert Galbraith | Reuters Horizon Therapeutics‘ stock price plunged more than 17% in early trading Tuesday after a report that the Federal Trade Commission is preparing...
CNBC’s Jim Cramer said that three corporate deals announced on Monday helped push stocks up. “Mergers matter. When companies start buying each other at a big...
Check out the companies making headlines in midday trading. Horizon Therapeutics – Shares of the drugmaker jumped 15% after the company announced it has agreed to be...
Take a look at some of the biggest movers in the premarket: Horizon Therapeutics (HZNP) – The drugmaker’s shares surged 14.7% in the premarket after it...
Robert Galbraith | Reuters Amgen will acquire Horizon Therapeutics, a biopharmaceutical company that focuses on treatments for rare, autoimmune diseases, in a deal valued at approximately...
Check out the companies making headlines in midday trading. Zscaler – The cloud security company’s shares dipped 10.7% following its quarterly earnings report, despite Zscaler posting...